Evidence map›Paper›PMID 37606044›Full record

ArticleJCI insight2023

Key patient demographics shape innate immune topography in noncritical hypoxic COVID-19 pneumonia.

Allison C Billi, Rachael Wasikowski, Feiyang Ma, Srilakshmi Yalavarthi, Claire K Hoy, Yu Zuo, Matthew T Patrick, Neha Shah, Christine Parker, Chad Aaronson and 11 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 1 country.

Allison C BilliDepartment of Dermatology.
Rachael WasikowskiDepartment of Dermatology.
Feiyang MaDivision of Rheumatology, Department of Internal Medicine.
Srilakshmi YalavarthiDivision of Rheumatology, Department of Internal Medicine.
Claire K HoyDivision of Rheumatology, Department of Internal Medicine.
Yu ZuoDivision of Rheumatology, Department of Internal Medicine.
Matthew T PatrickDepartment of Dermatology.
Neha ShahDivision of Cardiovascular Medicine, Department of Internal Medicine.
Christine ParkerA. Alfred Taubman Medical Research Institute.
Chad AaronsonDivision of Rheumatology, Department of Internal Medicine.
Alyssa HarbaughDivision of Rheumatology, Department of Internal Medicine.
Matthew F LucidoDivision of Rheumatology, Department of Internal Medicine.
Kerby SheddenDivision of Rheumatology, Department of Internal Medicine.
Krishna RaoDivision of Infectious Disease, Department of Internal Medicine.
Heidi B IglayRegerA. Alfred Taubman Medical Research Institute.
Charles F BurantA. Alfred Taubman Medical Research Institute.
J Michelle KahlenbergDepartment of Dermatology.
Lam C TsoiDepartment of Dermatology.
Johann E GudjonssonDepartment of Dermatology.
Jason S KnightDivision of Rheumatology, Department of Internal Medicine.
Yogendra KanthiDivision of Cardiovascular Medicine, Department of Internal Medicine.
Center for Rheumatology · USA. Alfred Taubman Health Care Center · USNational Heart Lung and Blood Institute · USUniversity of Michigan · US

Funding

University of Michigan Skin Biology and Diseases Resource-based CenterP30AR075043 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDRZEJ A. DLUGOSZ · 2019 to 2026
$6.6M
Purinergic modulation of the autoimmune vascular phenotypeR01HL134846 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jason Knight · 2018 to 2026
$4.8M
Human Translational Studies of Vascular Thrombosis and InflammationZIAHL006262 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KANTHI, YOGENDRA · 2021 to 2025
$4.7M
Vascular Immunobiology Mechanistic and Translational StudiesZIAHL006267 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KANTHI, YOGENDRA · 2021 to 2025
$4.6M
Unraveling Cytotoxic and Thrombotic Signals in Host-defense ResponsesZIAHL006263 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KANTHI, YOGENDRA · 2021 to 2025
$3.5M
Immunogenomics and Systems Biology CoreUC2AR081033 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Johann Eli Gudjonsson, Lam Cheung Tsoi · 2022 to 2026
$3.3M
Thromboinflammatory consequences of infection-induced autoimmunityK08AR080205 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Yu Zuo · 2022 to 2026
$865k
Mechanisms of sex discrepancy in autoimmune disease: Regulation of the female-biased VGLL3 immune pathwayK08AR078251 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BILLI, ALLISON CHELSA · 2021 to 2025
$865k
Integrative Biology Approach to Identify and Characterize Roles of lncRNAs Associated with Psoriasis PathologyK01AR072129 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TSOI, LAM CHEUNG · 2017 to 2021
$500k
Intramural NIH HHS ZIA HL006262Intramural NIH HHS ZIA HL006263Intramural NIH HHS ZIA HL006267NHLBI NIH HHS R01 HL134846NIAMS NIH HHS K01 AR072129NIAMS NIH HHS K08 AR078251NIAMS NIH HHS K08 AR080205NIAMS NIH HHS P30 AR075043NIAMS NIH HHS UC2 AR081033
6 · The paper itself

Abstract

Risk of severe disease and death due to COVID-19 is increased in certain patient demographic groups, including those of advanced age, male sex, and obese body mass index. Investigations of the biological variations that contribute to this risk have been hampered by heterogeneous severity, with immunologic features of critical disease potentially obscuring differences between risk groups. To examine immune heterogeneity related to demographic risk factors, we enrolled 38 patients hospitalized with clinically homogeneous COVID-19 pneumonia - defined as oxygen saturation less than 94% on room air without respiratory failure, septic shock, or multiple organ dysfunction - and performed single-cell RNA-Seq of leukocytes collected at admission. Examination of individual risk factors identified strong shifts within neutrophil and monocyte/dendritic cell (Mo/DC) compartments, revealing altered immune cell type-specific responses in higher risk COVID-19 patient subgroups. Specifically, we found transcriptional evidence of altered neutrophil maturation in aged versus young patients and enhanced cytokine responses in Mo/DCs of male versus female patients. Such innate immune cell alterations may contribute to outcome differences linked to these risk factors. They also highlight the importance of diverse patient cohorts in studies of therapies targeting the immune response in COVID-19.

Indexed as

COVID-19AgedBody Mass IndexCytokinesDemographyFemaleHumansHypoxiaImmunity, InnateMaleCytokinesCOVID-19ImmunologyInnate immunity

Identifiers

PMID37606044
PMCPMC10543737
OpenAlexW4386022214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.